Sökning: WFRF:(Poulsen Laurids)
> (2022) >
The Prognostic Valu...
The Prognostic Value of Pre-Treatment Circulating Biomarkers of Systemic Inflammation (CRP, dNLR, YKL-40, and IL-6) in Vulnerable Older Patients with Metastatic Colorectal Cancer Receiving Palliative Chemotherapy-The Randomized NORDIC9-Study
-
- Liposits, Gabor (författare)
- Odense Univ Hosp, Dept Oncol, DK-5000 Odense, Denmark.;Univ Southern Denmark, Dept Clin Res, DK-5000 Odense, Denmark.;Acad Geriatr Canc Res AgeCare, DK-5000 Odense, Denmark.
-
- Skuladottir, Halla (författare)
- Reg Hosp Godstrup, Dept Oncol, DK-7400 Herning, Denmark.
-
- Ryg, Jesper (författare)
- Univ Southern Denmark, Dept Clin Res, DK-5000 Odense, Denmark.;Acad Geriatr Canc Res AgeCare, DK-5000 Odense, Denmark.;Odense Univ Hosp, Dept Geriatr Med, DK-5000 Odense, Denmark.
-
visa fler...
-
- Winther, Stine Braendegaard (författare)
- Odense Univ Hosp, Dept Oncol, DK-5000 Odense, Denmark.;Acad Geriatr Canc Res AgeCare, DK-5000 Odense, Denmark.
-
- Moller, Soren (författare)
- Univ Southern Denmark, Dept Clin Res, DK-5000 Odense, Denmark.;Odense Univ Hosp, OPEN Open Patient Data Explorat Network, DK-5000 Odense, Denmark.
-
- Hofsli, Eva (författare)
- Trondheim Reg & Univ Hosp, Dept Oncol, N-7030 Trondheim, Norway.;Norwegian Univ Sci & Technol, Dept Clin & Mol Med, N-7030 Trondheim, Norway.
-
- Shah, Carl-Henrik (författare)
- Karolinska Univ Hosp, Theme Canc, S-17176 Stockholm, Sweden.
-
- Poulsen, Laurids Ostergaard (författare)
- Aalborg Univ Hosp, Dept Oncol, DK-9000 Aalborg, Denmark.
-
- Berglund, Åke (författare)
- Uppsala universitet,Institutionen för immunologi, genetik och patologi
-
- Qvortrup, Camilla (författare)
- Acad Geriatr Canc Res AgeCare, DK-5000 Odense, Denmark.
-
- Osterlund, Pia (författare)
- Karolinska Institutet
-
- Johansen, Julia S. (författare)
- Copenhagen Univ Hosp, Dept Med, DK-2730 Herlev, Denmark.;Copenhagen Univ Hosp, Dept Oncol, DK-2730 Herlev, Denmark.;Univ Copenhagen, Fac Hlth & Med Sci, Dept Clin Med, DK-2200 Copenhagen, Denmark.
-
- Glimelius, Bengt (författare)
- Uppsala universitet,Institutionen för immunologi, genetik och patologi
-
- Sorbye, Halfdan (författare)
- Haukeland Hosp, Dept Oncol, N-5021 Bergen, Norway.;Univ Bergen, Dept Clin Sci, N-5021 Bergen, Norway.
-
- Pfeiffer, Per (författare)
- Odense Univ Hosp, Dept Oncol, DK-5000 Odense, Denmark.;Univ Southern Denmark, Dept Clin Res, DK-5000 Odense, Denmark.;Acad Geriatr Canc Res AgeCare, DK-5000 Odense, Denmark.
-
visa färre...
-
Odense Univ Hosp, Dept Oncol, DK-5000 Odense, Denmark;Univ Southern Denmark, Dept Clin Res, DK-5000 Odense, Denmark.;Acad Geriatr Canc Res AgeCare, DK-5000 Odense, Denmark. Reg Hosp Godstrup, Dept Oncol, DK-7400 Herning, Denmark. (creator_code:org_t)
- 2022-09-23
- 2022
- Engelska.
-
Ingår i: Journal of Clinical Medicine. - : MDPI. - 2077-0383. ; 11:19
- Relaterad länk:
-
https://doi.org/10.3...
-
visa fler...
-
https://uu.diva-port... (primary) (Raw object)
-
https://urn.kb.se/re...
-
https://doi.org/10.3...
-
http://kipublication...
-
visa färre...
Abstract
Ämnesord
Stäng
- Appropriate patient selection for palliative chemotherapy is crucial in patients with metastatic colorectal cancer (mCRC). We investigated the prognostic value of C-reactive protein (CRP), derived neutrophil-to-lymphocyte ratio (dNLR), Interleukin (IL)-6, and YKL-40 on progression-free survival (PFS) and overall survival (OS) in the NORDIC9 cohort. The randomized NORDIC9-study included patients >= 70 years with mCRC not candidates for standard full-dose combination chemotherapy. Participants received either full-dose S1 (Teysuno) or a dose-reduced S1 plus oxaliplatin. Blood samples were collected at baseline and biomarkers were dichotomized according to standard cut-offs. Multivariable analyses adjusted for age, sex, ECOG performance status, and treatment allocation; furthermore, C-statistics were estimated. In total, 160 patients with a median age of 78 years (IQR: 76-81) were included between 2015 and 2017. All investigated biomarkers were significantly elevated in patients with either weight loss, >= 3 metastatic sites, or primary tumor in situ. In multivariable analyses, all markers showed significant association with OS; the highest HR was observed for CRP (HR = 3.40, 95%CI: 2.20-5.26, p < 0.001). Regarding PFS, statistically significant differences were found for CRP and IL-6, but not for dNLR and YKL-40. Applying C-statistics, CRP indicated a good prognostic model for OS (AUC = 0.72, 95%CI: 0.67-0.76). CRP is an easily available biomarker, which may support therapeutic decision-making in vulnerable older patients with mCRC.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Cancer och onkologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Cancer and Oncology (hsv//eng)
Nyckelord
- older patients
- colorectal cancer
- frailty
- biomarker
- C-reactive protein
- neutrophil-to-lymphocyte ratio
- Interleukin-6
- YKL-40
- chemotherapy
- survival
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Liposits, Gabor
-
Skuladottir, Hal ...
-
Ryg, Jesper
-
Winther, Stine B ...
-
Moller, Soren
-
Hofsli, Eva
-
visa fler...
-
Shah, Carl-Henri ...
-
Poulsen, Laurids ...
-
Berglund, Åke
-
Qvortrup, Camill ...
-
Osterlund, Pia
-
Johansen, Julia ...
-
Glimelius, Bengt
-
Sorbye, Halfdan
-
Pfeiffer, Per
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Cancer och onkol ...
- Artiklar i publikationen
-
Journal of Clini ...
- Av lärosätet
-
Uppsala universitet
-
Karolinska Institutet